A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/13 (2006.01) A61P 27/16 (2006.01) A61P 35/02 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2422535
The invention relates to the use of substances for the manufacturing of a pharmaceutical composition or medicament for the treatment of disturbances or illnesses which are linked to malfunction of an ionotropic acetylcholine receptor and/or a calcium-activated potassium channel functionally associated with said acetylcholine receptor, wherein said substance is at least one adamantane derivative.
L'invention porte sur l'utilisation de substances destinées à la fabrication d'une composition pharmaceutique ou d'un médicament pour le traitement de troubles ou maladies liés au dysfonctionnement d'un récepteur d'acétylcholine ionotropique et/ou d'une fonctionnalité des canaux de potassium activés par le calcium associée au récepteur d'acétylcholine. Cette substance est au moins un dérivé d'adamantane.
Fakler Bernd
Ruppersberg J. Peter
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Tinnitus Forschungs-Und Entwicklungs Gmbh
LandOfFree
Treatment of diseases with adamantane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diseases with adamantane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diseases with adamantane derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1743572